Answers are grounded in this paper and cite their sources.
The gut microbiota interacts with host metabolic and neuroendocrine processes, and nesfatin-1, derived from nucleobindin-2 (NUCB2), regulates appetite and energy homeostasis. We investigated whether post-weaning antibiotic-induced dysbiosis (DYS) is associated with altered NUCB2/nesfatin-1 signaling, feed intake, and growth, and whether fecal microbiota transplantation (FMT) is associated with partial recovery. After weaning, 28 male Sprague-Dawley rats were assigned to control (CON, n = 8), DYS (n = 10), or FMT (n = 10) groups. DYS was induced with vancomycin and amoxicillin for 2 weeks, followed by 10 days of FMT. Body weight and feed intake were monitored weekly. Cecal microbiota were characterized descriptively by shotgun sequencing of pooled samples. Plasma and cecal nesfatin-1 were measured by ELISA, cecal NUCB2 mRNA by qPCR, and gastric nesfatin-1 immunoreactivity by immunohistochemistry. DYS was associated with markedly fewer detected microbial taxa in the pooled cecal metagenome, reduced feed intake and body weight, higher plasma nesfatin-1 concentrations, higher cecal nesfatin-1 immunoreactivity and NUCB2 mRNA expression, and lower gastric nesfatin-1 immunoreactivity. After FMT, feed intake showed an increasing trend whereas body weight did not differ significantly from DYS; the nesfatin-1 and NUCB2 mRNA measures were lower and gastric immunoreactivity was higher, without reaching control values. DYS was thus associated with altered NUCB2/nesfatin-1-related outcomes, reduced feed intake, and lower body weight gain, and FMT was associated with partial attenuation of these changes.
No takes yet. Share an insight, caveat, or question.
Güvenç et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: